硕腾
ZTS
查看详细走势图
127.420USD
+0.715+0.56%
收盘 02/06, 16:00（美东）报价延迟15分钟
56.25B总市值
21.45市盈率 TTM
盘中分时
1分
30分
1小时
日k
周k
月k
日k
今天
+0.56%
5天
+2.08%
1月
+1.39%
6月
-14.04%
今年开始到现在
+1.27%
1年
-25.67%
查看详细走势图
TradingKey 硕腾股票评分
单位: USD 更新时间: 2026-02-06操作建议
硕腾当前公司基本面数据相对健康，最新ESG披露属于行业领先水平。增长潜力很大。当前估值合理，在药品行业排名27/159位。机构持股占比非常高，近一月多位分析师给出公司评级为买入。最高目标价156.33。中期看，股价处于平稳状态。近一个月，市场表现一般，但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间，可以做区间波段操作。
硕腾评分
压力支撑
由于公司未披露，未能获取相关数据
多维评测
本期评分
上期评分
公司舆情
过去24小时
热度
过冷
过热
中性
硕腾亮点
亮点风险
Zoetis Inc. is a global animal health company. The Company is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests and precision animal health. The Company operates through two segments: the United States (U.S.) and International. Within each of these operating segments, it offers a diversified product portfolio, including parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics, for both companion animal and livestock customers. It directly markets its products in approximately 45 countries across North America, Europe, Africa, Asia, Australia and South America. The Company is engaged in commercializing products across eight species: dogs, cats and horses (collectively, companion animals) and cattle, poultry, swine, fish and sheep (collectively, livestock).
利润高增长
公司净利润处于行业前列，最新年度总收入9.26B美元
高分红
公司属于高分红公司，最新股息支付率32.66%
稳定分红
公司5年内连续分红，最新股息支付率32.66%
估值低估
公司最新PE估值21.45，处于3年历史低位
Mairs and Power 公司持仓
明星投资者Mairs and Power 公司持仓，最新持仓市值7.22K
分析师目标
根据
20
位分析师
买入
评级
156.334
目标均价
+23.39%
涨幅空间
数据免责声明：分析师评级与目标价由LSEG提供，仅供参考，不应当作投资建议
财务指标
每股收益
由于公司未披露，未能获取相关数据
营业总收入
由于公司未披露，未能获取相关数据
硕腾简介
Zoetis Inc. is a global animal health company. The Company is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests and precision animal health. The Company operates through two segments: the United States (U.S.) and International. Within each of these operating segments, it offers a diversified product portfolio, including parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics, for both companion animal and livestock customers. It directly markets its products in approximately 45 countries across North America, Europe, Africa, Asia, Australia and South America. The Company is engaged in commercializing products across eight species: dogs, cats and horses (collectively, companion animals) and cattle, poultry, swine, fish and sheep (collectively, livestock).
公司代码ZTS
公司硕腾
CEOPeck (Kristin C)
网址https://www.zoetis.com/
相关品种
